Article

Beezin’: The hazardous TikTok trend involving Burt’s Bees

Author(s):

Ophthalmologists could find themselves treating a growing number of young people who are applying lip balm to their eyelids, only to experience discomfort and vision issues when it gets into their eyes.

Applying Burt's Bees to the eyelids can result in chemical irritation to the eyelids themselves, and ophthalmologists will see redness, swelling, and inflammation in these patients. (Adobe Stock image)

Applying Burt's Bees to the eyelids can result in chemical irritation to the eyelids themselves, and ophthalmologists will see redness, swelling, and inflammation in these patients. (Adobe Stock image)

Just when you thought you’d seen it all when it comes to the things that people will try, the TikTok trend of “beezin’” is sending people to the ophthalmologist’s office.

Beezin' is a fad where people apply Burt’s Bees lip balm to their eyelids. The menthol or peppermint flavors are supposed to cause a sensation of enhanced alertness. It first started in the 2010s and is apparently making a comeback this year on TikTok, according to a Michigan Medicine-University of Michigan news release.

According to Olivia J. Killeen, MD, a clinical lecturer in the Department of Ophthalmology and Visual Sciences at Michigan Medicine, it is not actually effective and will only cause the same sensation on the eyelids that the balm causes when applied to the lips.

“The peppermint oil or menthol in the balm can cause a tingling sensation, but it is not actually getting people high or causing the same type of chemical reaction in the body that’s produced by drugs or alcohol,” Killeen said.

It is believed that the individuals are experiencing a tingling or burning sensation from the lip balm’s peppermint oil. But the peppermint oil can also be a strong irritant to the eye.

What can happen is chemical irritation to the eyelids themselves, and ophthalmologists will see redness, swelling, and inflammation in these patients.

Kileen also noted in the Michigan Medicine report the products can accidentally get into the eyes themselves. So, beezin’ can end up causing tearing, redness, and painful burns to the surface of the eyes. In severe instances, it could lead to scarring or vision loss.

Moreover, whenever viruses or bacteria are introduced to the surface of the eye, beezin’ may also increase the risk of infection, especially if the lip balm is applied to the eyelids after it was already used on the lips.

Killeen says in some cases, viruses or bacteria from the lips could cause conjunctivitis, commonly known as pink eye. On a more serious level, it may cause infections and ulcers of the eye that can be difficult to treat and lead to permanent vision loss.

Ophthalmologists will treat patients who have tried this, and Killeen noted that the issues can sometimes be resolved just by stopping the practice, but some may require additional treatment. The treatment could involve artificial tears or other medications including steroids, antibiotics or antihistamines.

“Eyes and vision are precious, and both the eyeballs and the eyelids are very sensitive,” Killeen said in the report. “Any trend like this is generally a bad idea. Products that are not designed for your eyes should not be used in or around your eyes.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.